Company / CapEx per Share
CHAMPIONS ONCOLOGY, INC. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.06
FY2025
5-year range
$0.03 / $0.24
FY2021-FY2025
Trend
+114.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share returned to growth in FY2025 after 2 years of decline, reaching $0.06.
Based on SEC 10-K filings.
0.06 in FY2025 with a 5-year CAGR of -26.3%.
Declined from $0.18 to $0.06 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -36.9%
- 5-Year CAGR
- -26.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, capex per share increased 114.1% year-over-year.
- Peak capex per share was recorded in FY2020.
- Lowest capex per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.06 | +114.1% |
| FY2024 | $0.03 | -83.7% |
| FY2023 | $0.18 | -27.9% |
| FY2022 | $0.24 | +40.2% |
| FY2021 | $0.17 | -38.2% |
| FY2020 | $0.28 | +40.0% |
| FY2019 | $0.20 | +189.3% |
| FY2018 | $0.07 | +88.6% |
| FY2017 | $0.04 | +170.2% |
| FY2016 | $0.01 | +291.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026